Non-Invasive Monitoring Systems

Non-Invasive Monitoring Systems AAQS

O O AAQS de Non-Invasive Monitoring Systems (NIMU) em 19 de out. de 2026 é 3. No ano anterior, O AAQS foi 3,00 — uma variação de 0,00% (inferior).

AAQS

3

YoY

0,00%

Última atualização:

Non-Invasive Monitoring Systems tem um AAQS atual de 3.

Um alto AAQS pode ser considerado um indicativo positivo de que a empresa está se desenvolvendo com sucesso.

Os investidores podem assumir que a empresa está no caminho certo para obter lucros.

Por outro lado, é importante considerar o AAQS da ação Non-Invasive Monitoring Systems em comparação aos lucros obtidos e a outras empresas do mesmo setor. Um alto AAQS não é uma garantia absoluta de um futuro positivo. Apenas desta maneira, é possível obter uma imagem completa do desempenho da empresa.

Para melhor avaliar o desenvolvimento da empresa, é importante comparar o AAQS com outras empresas do mesmo setor. Em geral, os investidores devem sempre considerar o AAQS de uma empresa em conjunto com outros indicadores, como lucro, EBIT, fluxo de caixa e outros, para fazer uma decisão de investimento fundamentada.

A Non-Invasive Monitoring Systems AAQS História

  • 3 anos

  • 10 anos

  • 25 anos

  • Max

AAQS
Data
AAQS
1 de jan. de 2019
3,00 USD
1 de jan. de 2020
3,00 USD
1 de jan. de 2021
3,00 USD
1 de jan. de 2022
3,00 USD
1 de jan. de 2023
3,00 USD
1 de jan. de 2024
3,00 USD
1 de jan. de 2025
3,00 USD
1 de jan. de 2026
3,00 USD
A Non-Invasive Monitoring Systems AAQS História
ANOAAQSYoY
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
30,00%
3—

Aceda a estes dados via API Eulerpool

100.000 pedidos/mês grátis · sem cartão

Non-Invasive Monitoring Systems Análise de ações

O que Non-Invasive Monitoring Systems faz? Non-Invasive Monitoring Systems Inc (NIMS) has become a major player in the field of medical diagnostics and monitoring in recent years. The company was founded in 2002 and is headquartered in Miami, Florida. Its focus is on developing and marketing innovative non-invasive technologies that enable better patient care. NIMS' business model is based on the development and marketing of products that allow for fast and accurate diagnosis of various medical conditions. These technologies can be used in various clinical areas such as intensive care, oncology, cardiology, and neurology. The company's goal is to improve patient care by making diagnostics and monitoring faster, more accurate, and more effective. NIMS has several divisions that focus on different medical applications. One of these is the gastrointestinal division, which specializes in the diagnosis and monitoring of gastrointestinal disorders. NIMS offers innovative technologies such as magnetic resonance elastography (MRE-MRI), which allows for the measurement of tissue hardness without invasive procedures. This technology is particularly used in the early detection of cancer, as it enables the detection of tissue changes at an early stage. Another important division of NIMS is cardiovascular monitoring, which aims at the early detection and monitoring of heart diseases. The company offers various non-invasive technologies for this purpose, such as wearable devices for measuring blood pressure and heart rate, or ultrasound for measuring blood flow and vascular stiffness. These technologies are intended to improve the monitoring of patients with heart diseases and to detect complications at an early stage. NIMS also offers innovative diagnostic tools for the early detection of cancer, such as the Cancer Screening Index (CSI). The CSI is a biomarker-based test that calculates the probability of developing certain types of cancer. Various factors such as family history, smoking, or age are taken into account in the calculation. The CSI aims to contribute to the early detection of cancer and thus enable better prognosis. In addition to these products, NIMS is also involved in clinical research. The company offers specialized services such as conducting clinical trials or providing expert opinions. These services are intended to promote the development of new non-invasive diagnostic and monitoring technologies and thus improve overall patient care. Overall, NIMS has become a leading company in the field of non-invasive medical diagnostics and monitoring. The company is constantly striving to advance the development of new innovative technologies to improve patient care and minimize the use of invasive procedures. With its various divisions and products, NIMS is able to cover various medical applications and thus appeal to a broad customer base. Non-Invasive Monitoring Systems é uma das empresas mais populares na Eulerpool.com.

Perguntas frequentes sobre ação Non-Invasive Monitoring Systems

O AAQS de Non-Invasive Monitoring Systems é 3 em 2026.

Na Eulerpool você encontra o histórico completo do Non-Invasive Monitoring Systems de O AAQS desde 2006, com valores anuais, gráficos e análises detalhadas.

O AAQS é um indicador desenvolvido pela AlleAktien.

O AAQS é um indicador desenvolvido pela AlleAktien.

Aceda a estes dados via API Eulerpool

100.000 pedidos/mês grátis · sem cartão

Qualidade — Non-Invasive Monitoring Systems

Todas as Métricas Financeiras — Non-Invasive Monitoring Systems